Lamivudine therapy for children with chronic hepatitis B

World Journal of Gastroenterology

Volumn 12, Issue 15, 2006, Pages 2412-2416

  Liberek, Anna ^a   Szaflarska Popławska, Anna ^a   Korzon, Maria ^a   Łuczak, Grazyna ^a   Góra Gebka, Magdalena ^a   Łoś Rycharska, Ewa ^a   Bako, Wanda ^a   Czerwionka Szaflarska, Mieczysława ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Children; Chronic hepatitis B; Lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; RECOMBINANT ALPHA INTERFERON; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; BONE MARROW TOXICITY; CHILD; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERVIEW; KIDNEY DYSFUNCTION; LABORATORY TEST; LIVER BIOPSY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PEDIATRICS; QUESTIONNAIRE; SCORING SYSTEM; SEROCONVERSION; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 33646441900     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i15.2412     Document Type: Article

References (30)

1. Louis-Jacques O, Olson AD. Cost-benefit analysis of interferon therapy in children with chronic active hepatitis B. J Pediatr Gastroenterol Nutr 1997; 24: 25-32
2. Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993; 12: 433-437
3. Bortolotti F, Calzia R, Cadrobbi P, Giacchini R, Ciravegna B, Armigliato M, Piscopo R, Realdi G. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood. J Pediatr 1986; 108: 224-227
4. Ruiz-Moreno M. Chronic hepatitis B in children. Natural history and treatment. J Hepatol 1993; 17 (Suppl 3): S64-S66
5. Sokal EM, Kelly D, Mizierski Jl. An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B. J Hepatol 2001; 34 (Suppl 1): 23
6. Woynarowski M, Socha J. Results of interferon alfa therapy in children with chronic viral hepatitis type B. Experiences of Polish centres 1990-1997. Ped. Pol 1998; 10: 1031-1041 (in Polish with English abstract)
7. Terminology of chronic hepatitis. International Working Party. Am J Gastroenterol 1995; 90: 181-189
8. Iorio R, Pensati P, Botta S, Moschella S, Impagliazzo N, Vajro P, Vegnente A. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997; 16: 984-990
9. Dixon JS, Boehme RE. Lamivudine for the treatment of chronic hepatitis B. Acta Gastroenterol Belg 2000; 63: 348-356
10. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341: 1256-1263
11. Kocak N, Ozen H, Saltik IN, Gurakan F, Yuce A. Lamivudine for children with chronic hepatitis B. Am J Gastroenterol 2000; 95: 2989-2990
12. Jonas MM, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706-1713
13. Figlerowicz M, Kowala-Piaskowska A, Filipowicz M, Bujnowska A, Mozer-Lisewska I, Sluzewski W. Efficacy of lamivudine in the treatment of children with chronic hepatitis B. Hepatol Res 2005;
14. Hartman C, Berkowitz D, Shouval D, Eshach-Adiv O, Hino B, Rimon N, Satinger I, Kra-Oz T, Daudi N, Shamir R. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Pediatr Infect Dis J 2003; 22: 224-229
15. Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. The HBeAg/ antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy. Pol Merkuriusz Lek 2004; 16: 557-559
16. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004; 2: 87-106
17. Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003; 38: 1419-1427
18. Selimoglu MA, Aydogdu S, Unal F, Zeytinoglu A, Yuce G, Yagci RV. Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children. Pediatr Int 2002; 44: 404-408
19. Dikici B, Ozgenc F, Kalayci AG, Targan S, Ozkan T, Selimoglu A, Doganci T, Kansu A, Tosun S, Arslan N, Kasirga E, Bosnak M, Haspolat K, Buyukgebiz B, Aydogdu S, Girgin N, Yagci RV. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. J Gastroenterol Hepatol 2004; 19: 127-133
20. Rosenberg PM, Dienstag JL. Therapy with nucleoside analogues for hepatitis B virus infection. Clin Liver Dis 1999; 3: 349-361
21. Dikici B, Bosnak M, Bosnak V, Dagli A, Davutoglu M, Yagci RV, Haspolat K. Comparison of treatments of chronic hepatitis B in children with lamivudine and alpha-interferon combination and alpha-interferon alone. Pediatr Int 2002; 44: 517-521
22. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L, Gray DF. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B.Lamivudine Precore Mutant Study Group. Hepatology 1999; 29: 889-896
23. Da Silva LC, da Fonseca LE, Carrilho FJ, Alves VA, Sitnik R, Pinho JR. Predictive factors for response to lamivudine in chronic hepatitis B. Rev Inst Med Trop Sao Paulo 2000; 42: 189-196
24. Sokal E. Drug treatment of pediatric chronic hepatitis B. Paediatr Drugs 2002; 4: 361-369
25. Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J 2004; 23: 441-445
26. Sokal EM, Roberts EA, Mieli-Vergani G, McPhillips P, Johnson M, Barber J, Dallow N, Boxall E, Kelly D. A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B. Antimicrob Agents Chemother 2000; 44: 590-597
27. Lebensztejn DM, Kaczmarski M. Lamivudine-associated thrombocytopenia. Am J Gastroenterol 2002; 97: 2687-2688
28. Hussain M, Lok AS. Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B. J Viral Hepat 1999; 6: 183-194
29. Liaw YF, Lai CL, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY. Two-year lamivudne therapy in chronic hepatitis B infection: results of a placebo controlled multi-centre study in Asia. Gastroenterology 1998; 114: 1289
30. Leung N. Liver disease-significant improvement with lamivudine. J Med Virol 2000; 61: 380-38.